The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Alto Neuroscience Inc. shares valued at $100,628 were purchased by Smith Nicholas Conrad on Mar 28 ’24. At $16.36 per share, Smith Nicholas Conrad acquired 6,150 shares. The insider’s holdings grew to 26,866 shares worth approximately $0.31 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Alpha Wave Global, LP purchased 600,000 shares, netting a total of over 9,600,000 in proceeds. Following the buying of shares at $16.00 each, the insider now holds 3,707,757 shares.
Before that, Savitz Adam had added 17,000 shares to its account. In a trade valued at $272,000, the CHIEF MEDICAL OFFICER bought Alto Neuroscience Inc. shares for $16.00 each. Upon closing the transaction, the insider’s holdings increased to 17,000 shares, worth approximately $0.29 million.
As published in their initiating research note from William Blair on February 27, 2024, Alto Neuroscience Inc. [ANRO] has been an Outperform. Analysts at TD Cowen started covering the stock with ‘”an Outperform”‘ outlook in a report released in late February. As of February 27, 2024, Stifel has initiated its “Buy” rating for ANRO. Earlier on February 27, 2024, Robert W. Baird initiated its rating. Their recommendation was “an Outperform” for ANRO stock.
Analyzing ANRO Stock Performance
During the last five days, there has been a surge of approximately 16.97%. Over the course of the year, Alto Neuroscience Inc. shares have dropped approximately -43.72%. Nevertheless, trading volume fell to 55665.0 shares from 0.12 million shares the previous day.
Support And Resistance Levels for Alto Neuroscience Inc. (ANRO)
According to the 24-hour chart, there is a support level at 11.14, which, if violated, would cause prices to drop to 10.66. In the upper region, resistance lies at 11.89. The next price resistance is at 12.17. RSI (Relative Strength Index) is 50.91 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.37, which suggests the price will decrease in the coming days. Percent R is at 18.68%, indicating bullish price movement. Stochastics%K at holding indicates that the stock is to be held.
